The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?
{{output}}
Purpose of review: Glucocorticoids have been the mainstay of treatment in systemic lupus erythematosus for more than half a century. Despite advancements in knowledge concerning the pathophysiology of systemic lupus, the genomic/... ...
